Edie Dullaghan

905 total citations
12 papers, 741 citations indexed

About

Edie Dullaghan is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Edie Dullaghan has authored 12 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Epidemiology. Recurrent topics in Edie Dullaghan's work include Biochemical and Molecular Research (2 papers), Immune Response and Inflammation (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Edie Dullaghan is often cited by papers focused on Biochemical and Molecular Research (2 papers), Immune Response and Inflammation (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Edie Dullaghan collaborates with scholars based in Canada, United States and United Kingdom. Edie Dullaghan's co-authors include Robert E. W. Hancock, B. Brett Finlay, Céline Cosseau, Avinash Chikatamarla, Jelena Pistolic, John Tagg, Deirdre DeVine, Jennifer L. Gardy, Shaan L. Gellatly and Reza Falsafi and has published in prestigious journals such as Nature Biotechnology, PLoS ONE and Cancer Research.

In The Last Decade

Edie Dullaghan

12 papers receiving 724 citations

Peers

Edie Dullaghan
Mary Cloud B. Ammons United States
Edie Dullaghan
Citations per year, relative to Edie Dullaghan Edie Dullaghan (= 1×) peers Mary Cloud B. Ammons

Countries citing papers authored by Edie Dullaghan

Since Specialization
Citations

This map shows the geographic impact of Edie Dullaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edie Dullaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edie Dullaghan more than expected).

Fields of papers citing papers by Edie Dullaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edie Dullaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edie Dullaghan. The network helps show where Edie Dullaghan may publish in the future.

Co-authorship network of co-authors of Edie Dullaghan

This figure shows the co-authorship network connecting the top 25 collaborators of Edie Dullaghan. A scholar is included among the top collaborators of Edie Dullaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edie Dullaghan. Edie Dullaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Geissner, Andreas, Lars Baumann, Thomas Morley, et al.. (2021). 7-Fluorosialyl Glycosides Are Hydrolysis Resistant but Readily Assembled by Sialyltransferases Providing Easy Access to More Metabolically Stable Glycoproteins. ACS Central Science. 7(2). 345–354. 20 indexed citations
2.
Vong, Kenward, et al.. (2018). Cellular Studies of an Aminoglycoside Potentiator Reveal a New Inhibitor of Aminoglycoside Resistance. ChemBioChem. 19(19). 2107–2113. 6 indexed citations
3.
Leung, Ada W.Y., Chansey J. Veinotte, Ian Backstrom, et al.. (2016). Abstract 3792: PAPSS1 (3’-phosphoadenosine 5’-phosphosulfate synthase 1) inhibition sensitizes non-small cell lung cancer to cisplatin treatment in vivo. Cancer Research. 76(14_Supplement). 3792–3792. 1 indexed citations
4.
Kumar, Nag S., Edie Dullaghan, B. Brett Finlay, et al.. (2014). Discovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections. Bioorganic & Medicinal Chemistry. 22(5). 1708–1725. 38 indexed citations
5.
Zoraghi, Roya, Sara C. Campbell, Edie Dullaghan, et al.. (2014). Discovery of a 1,2-bis(3-indolyl)ethane that selectively inhibits the pyruvate kinase of methicillin-resistant Staphylococcus aureus over human isoforms. Bioorganic & Medicinal Chemistry Letters. 24(21). 5059–5062. 15 indexed citations
6.
Bergqvist, Peter, Alireza Heravi‐Moussavi, Edie Dullaghan, et al.. (2014). A Pan-Cancer Analysis of Alternative Splicing Events Reveals Novel Tumor-Associated Splice Variants of Matriptase. Cancer Informatics. 13. CIN.S19435–CIN.S19435. 10 indexed citations
7.
Fan, Jianjia, Yoko Shimizu, Jeniffer Chan, et al.. (2013). Hormonal modulators of glial ABCA1 and apoE levels. Journal of Lipid Research. 54(11). 3139–3150. 13 indexed citations
8.
Bolouri, Hayde, Karin Sävman, Wei Wang, et al.. (2013). Innate defense regulator peptide 1018 protects against perinatal brain injury. Annals of Neurology. 75(3). 395–410. 57 indexed citations
9.
Ehrnhoefer, Dagmar E., Niels H. Skotte, Jane Savill, et al.. (2011). A Quantitative Method for the Specific Assessment of Caspase-6 Activity in Cell Culture. PLoS ONE. 6(11). e27680–e27680. 25 indexed citations
10.
Cosseau, Céline, Deirdre DeVine, Edie Dullaghan, et al.. (2008). The Commensal Streptococcus salivarius K12 Downregulates the Innate Immune Responses of Human Epithelial Cells and Promotes Host-Microbe Homeostasis. Infection and Immunity. 76(9). 4163–4175. 236 indexed citations
11.
Scott, Monisha G., Edie Dullaghan, Neeloffer Mookherjee, et al.. (2007). An anti-infective peptide that selectively modulates the innate immune response. Nature Biotechnology. 25(4). 465–472. 317 indexed citations
12.
Malloff, Chad A., Edie Dullaghan, Alice Li, et al.. (2003). Two-dimensional DNA displays for comparisons of bacterial genomes. Biological Procedures Online. 5(1). 143–153. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026